Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial

IMPORTANCE: Dupilumab subcutaneous injection is approved for treating moderate-to-severe atopic dermatitis (AD) in adolescents, but there has been too little research on an efficacious systemic oral treatment with a favorable benefit-risk profile for adolescents with moderate-to-severe AD. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichenfield, Lawrence F., Flohr, Carsten, Sidbury, Robert, Siegfried, Elaine, Szalai, Zsuzsanna, Galus, Ryszard, Yao, Zhirong, Takahashi, Hidetoshi, Barbarot, Sébastien, Feeney, Claire, Zhang, Fan, DiBonaventura, Marco, Rojo, Ricardo, Valdez, Hernan, Chan, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374743/
https://www.ncbi.nlm.nih.gov/pubmed/34406366
http://dx.doi.org/10.1001/jamadermatol.2021.2830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374743/
https://www.ncbi.nlm.nih.gov/pubmed/34406366
http://dx.doi.org/10.1001/jamadermatol.2021.2830

Ejemplares similares